IceCure Medical (NASDAQ:ICCM – Get Free Report) and Beauty Health (NASDAQ:SKIN – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, risk, institutional ownership, earnings, profitability and analyst recommendations.
Risk and Volatility
IceCure Medical has a beta of 0.41, indicating that its stock price is 59% less volatile than the S&P 500. Comparatively, Beauty Health has a beta of 0.88, indicating that its stock price is 12% less volatile than the S&P 500.
Profitability
This table compares IceCure Medical and Beauty Health’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| IceCure Medical | -376.85% | -124.44% | -87.70% |
| Beauty Health | -8.11% | -44.83% | -3.54% |
Valuation and Earnings
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| IceCure Medical | $3.29 million | 17.88 | -$14.65 million | ($0.30) | -3.53 |
| Beauty Health | $334.29 million | 0.39 | -$100.12 million | ($0.43) | -2.44 |
IceCure Medical has higher earnings, but lower revenue than Beauty Health. IceCure Medical is trading at a lower price-to-earnings ratio than Beauty Health, indicating that it is currently the more affordable of the two stocks.
Institutional & Insider Ownership
0.6% of IceCure Medical shares are held by institutional investors. Comparatively, 93.3% of Beauty Health shares are held by institutional investors. 2.4% of IceCure Medical shares are held by company insiders. Comparatively, 41.0% of Beauty Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Analyst Recommendations
This is a breakdown of current recommendations for IceCure Medical and Beauty Health, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| IceCure Medical | 0 | 0 | 1 | 1 | 3.50 |
| Beauty Health | 1 | 3 | 1 | 0 | 2.00 |
IceCure Medical currently has a consensus price target of $2.50, suggesting a potential upside of 135.85%. Beauty Health has a consensus price target of $2.45, suggesting a potential upside of 133.33%. Given IceCure Medical’s stronger consensus rating and higher probable upside, analysts plainly believe IceCure Medical is more favorable than Beauty Health.
Summary
Beauty Health beats IceCure Medical on 8 of the 14 factors compared between the two stocks.
About IceCure Medical
IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
About Beauty Health
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.
Receive News & Ratings for IceCure Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IceCure Medical and related companies with MarketBeat.com's FREE daily email newsletter.
